Background: Coronary artery disease (CAD) and myocardial infarction are the most common
causes of mortality and morbidity all over the world. Aspirin resistance is an important part of …

Aspirin resistance is an emerging clinical entity. However the data available on aspirin
resistance in Asian population is scarce. This study was initiated to prospectively evaluate …

Objectives: The aim of this study was to estimate the prevalence of aspirin resistance among
patients with coronary artery disease (CAD) in Egypt and evaluate its impact on clinical …

Objective Aspirin is a key drug used in treating patients with a high risk to develop stroke,
myocardial infarction and other cardiovascular events. However, a considerable fraction of …

Background Aspirin resistance is considered to be an enigma and the data available on
aspirin resistance is scarce. This study was initiated to prospectively evaluate the …

Aspirin reduces the odds of serious atherothrombotic vascular events and death in a broad
category of high risk patients by about one quarter. The term 'aspirin resistance'has been …

Aspirin (acetylsalicylic acid) is a powerful antiplatelet agent used in prevention of
atherothrombotic vascular events. However, antiplatelet effect of aspirin is not uniform and …

Aspirin is an effective antiplatelet drug for preventing thrombo-embolic vascular events.
However, clinical and laboratory evidence demonstrates diminished or no response to …

Aspirin is a key player in the management and prevention of stroke and myocardial
infarction in patients with atherothrombosis. About 12% of Pakistanis suffering from coronary …

Objective To evaluate the prevalence of pharmacological resistance to aspirin therapy by
measuring platelet functions using the technique of light transmission aggregometry …